The American College of Rheumatology and the Vasculitis Foundation have released new guidelines for Kawasaki disease, focusing on diagnostic issues, high-risk patients and convalescent patient management.
“Kawasaki disease continues to be an area of evolving understanding in clinical treatment,” said Mark Gorelik, MD, an assistant professor at Columbia University Vagelos College of Physicians and Surgeons in New York, and the lead investigator of the guideline, said in a press release. “These guidelines will help clinicians better treat patients by augmenting existing